Results 21 to 30 of about 1,399,233 (310)

Identification of a Conserved, Linear Epitope on VP3 of Enterovirus A Species Recognized by a Broad-Spectrum Monoclonal Antibody

Viruses, 2023
Outbreaks of hand, foot and mouth disease (HFMD) have occurred frequently in the Asian-Pacific region over the last two decades, caused mainly by the serotypes in Enterovirus A species.
Lie Fu, Xiao-Yu Zhang, Wei-Ping Jin, Chen Wang, Sha-Sha Qian, Meng-Jun Wang, Wen-Hui Wang, Sheng-Li Meng, Jing Guo, Ze-Jun Wang, Xiao-Qi Chen, Shuo Shen   +11 more
doaj   +1 more source

Citrus By-Products as a Valuable Source of Biologically Active Compounds with Promising Pharmaceutical, Biological and Biomedical Potential

, 2023
Citrus fruits processing results in the generation of huge amounts of citrus by-products, mainly peels, pulp, membranes, and seeds. Although they represent a major concern from both economical and environmental aspects, it is very important to emphasize ...
Silvija Šafranko, Igor Jerković, Stela Jokić, Drago Šubarić   +3 more
core   +1 more source

Validation of the detection method for residual human coagulation factor Ⅺ in human prothrombin complex

Zhongguo shuxue zazhi, 2023
Objective To establish an enzyme-linked immunosorbent assay (ELISA) method for the determination of residual human coagulation factor Ⅺ in human prothrombin complex and validate the method.
Yong LIU, Yurong YU, Long YANG, Zexiu LI, Yao ZHANG, Jing DENG, Dan LI, Yunhua CHEN, Xuemei ZHAO   +8 more
doaj   +1 more source

Trends in Biological Ammonia Production

BioTech, 2023
Food production heavily depends on ammonia-containing fertilizers to improve crop yield and profitability. However, ammonia production is challenged by huge energy demand, the release of ~2% of global CO2, and political instability. To mitigate this challenge, many research efforts have developed bioprocessing technologies to make biological ammonia ...
Adewale Adeniyi, Ibrahim Bello, Taofeek Mukaila, Niloy Chandra Sarker, Ademola Hammed   +4 more
openaire   +3 more sources

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study

Human Vaccines & Immunotherapeutics, 2022
To control seasonal influenza epidemics in elders, a quadrivalent, inactivated, split-virion influenza vaccine (IIV4) comprising A and B lineages is produced for young individuals and adults aged ≥60 years.
Renfeng Fan, Xiaoyuan Huang, Xuanxuan Nian, Zhiqiang Ou, Jian Zhou, Jiayou Zhang, Peiyu Zeng, Wei Zhao, Jinglong Deng, Wei Chen, Shaomin Chen, Kai Duan, Yingshi Chen, Xinguo Li, Jikai Zhang, Xiaoming Yang   +15 more
doaj   +1 more source

Repeat-Dose Toxicity of Candidate Omicron COVID-19 Vaccine in Sprague-Dawley Rats

COVID, 2022
Due to a large number of mutations in the spike protein and immune escape, the Omicron variant (B.1.1.529) has become a predominant variant of concern (VOC) strain.
Yuxiu Zhao, Zhenyu He, Zhanhui Wang, Yao He, Xue Zhao, Hongyang Liang, Yancen Guo, Yichuan Wang, Xiaonan Zhang, Huiqin Zhu, Yuan Dong, Yingwei Liu, Wanli Li, Ling Ding, Xiujuan Zhu, Haoyue Lan, Yuntao Zhang, Hui Wang, Xiaoming Yang   +18 more
doaj   +1 more source

Quality Evaluation of Bee Products

, 2023
Bee products, such as honey, bee pollen, bee bread, royal jelly, propolis, and bee-related insect foods, are widely consumed as natural/functional foods or supplements, owing to their nutritional/bioactive characteristics, which are beneficial to human ...

core   +1 more source

Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution

Vaccines, 2022
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread to more than 230 countries and territories worldwide since its outbreak in late 2019. In less than three years, infection by SARS-CoV-2 has
Lili Li, Yangyang Wei, Han Yang, Junyu Yan, Xin Li, Ziqian Li, Yuxiu Zhao, Hongyang Liang, Hui Wang   +8 more
doaj   +1 more source

Study on thedistribution of high titer neutralizing antibody against human cytomegalovirus in plasma donors

Zhongguo shuxue zazhi, 2022
Objective To investigate the distribution of plasma donors with high titer neutralizing antibodies against human cytomegalovirus (HCMV) in the general plasma donor population. Methods 920 plasma samples of Taibang were tested in April 2014 to investigate
Junying SHEN, Wenjuan GE, Xiaoqing LI, Lele YANG, Yanyan GONG, Jie MA   +5 more
doaj   +1 more source

Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments

Viruses, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused huge social and economic distress. Given its rapid spread and the lack of specific treatment options, SARS-CoV-2 needs to be inactivated according to strict biosafety measures during
Shouzhi Yu, Yangyang Wei, Hongyang Liang, Wenheng Ji, Zhen Chang, Siman Xie, Yichuan Wang, Wanli Li, Yingwei Liu, Hao Wu, Jie Li, Hui Wang, Xiaoming Yang   +12 more
doaj   +1 more source